je.st
news
FDA Accepts OPKO's New Drug Application For Rayaldee
2015-07-30 02:52:44| drugdiscoveryonline News Articles
OPKO Health, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has accepted for review OPKO’s New Drug Application (NDA) for calcifediol modified-release capsules (proposed trade name, Rayaldee).
Tags: application
drug
accepts
fda
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||